PRDM2 Gene

HGNC Family Chromatin-modifying enzymes
Name PR domain containing 2, with ZNF domain
Description This tumor suppressor gene is a member of a nuclear histone/protein methyltransferase superfamily. It encodes a zinc finger protein that can bind to retinoblastoma protein, estrogen receptor, and the TPA-responsive element (MTE) of the heme-oxygenase-1 gene. Although the functions of this protein have not been fully characterized, it may (1) play a role in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma, (2) act as a transcriptional activator of the heme-oxygenase-1 gene, and (3) be a specific effector of estrogen action. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPRDM2 (also known as RIZ1) encodes a nuclear protein that contains a conserved PR/SET domain conferring histone methyltransferase activity—most notably the methylation of histone H3 at lysine 9—that is intimately linked to transcriptional repression and tumor‐suppressive functions. Multiple studies have shown that this epigenetic modification helps silence oncogenic pathways (for example, by repressing insulin‐like growth factor–1 and attenuating Akt3 signaling), and that loss or reduction of RIZ1 activity—whether by mutation, frameshift alterations, or aberrant promoter hypermethylation—correlates with the development and progression of diverse malignancies such as chronic myelogenous leukemia, hematologic neoplasms, and colorectal cancer. Moreover, dietary methyl donor deficiency was shown to impair its methyltransferase activity, thereby offering a mechanistic link between nutrition and carcinogenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA large body of evidence further indicates that RIZ1 is frequently inactivated in cancer cells via epigenetic mechanisms. Detailed analyses in various tumor types have documented frameshift mutations and loss of heterozygosity (LOH), as well as extensive CpG island promoter hypermethylation, leading to reduced mRNA and protein expression of PRDM2. These modifications have been observed in contexts ranging from gastric and thyroid cancers to pheochromocytomas, cervical neoplasms, and adult acute lymphoblastic leukemia. In addition, genetic variants in PRDM2 and related epigenetic regulators appear to modulate cancer susceptibility, while pharmacologic demethylation agents can restore RIZ1 expression in cell‐based models."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its core tumor‐suppressive functions, PRDM2 plays a significant role in modulating hormonal and growth‐related signaling pathways. In estrogen‐responsive tissues, for instance, RIZ1 acts as a potent co-activator of estrogen receptor α, thereby influencing bone mineral density and possibly the progression of hormone-dependent cancers such as prostate and pituitary adenomas. Other studies have highlighted that changes in RIZ1 expression may impact downstream effectors (including c-Myc and Akt3) and alter cell proliferation and apoptotic responses in somatotroph adenomas, gliomas, and even T lymphocytes during activation. These findings not only underscore the multifaceted regulatory role of PRDM2 in cellular differentiation and survival but also suggest that imbalances between the tumor-suppressive full‐length isoform (RIZ1) and its shorter counterpart (RIZ2) may shift the equilibrium toward oncogenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Y Du, T Carling, W Fang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2001)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11719434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11719434"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Keun-Cheol Kim, Liqing Geng, Shi Huang "}, {"type": "b", "children": [{"type": "t", "text": "Inactivation of a histone methyltransferase by mutations in human cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14633678"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14633678"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "E Pastural, N Takahashi, W-F Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1209959"}], "href": "https://doi.org/10.1038/sj.onc.1209959"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16953217"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16953217"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Wenyun Zhou, Sergio Alonso, Daisaku Takai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Requirement of RIZ1 for cancer prevention by methyl-balanced diet."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0003390"}], "href": "https://doi.org/10.1371/journal.pone.0003390"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18852888"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18852888"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ashakumary Lakshmikuttyamma, Naoto Takahashi, Elodie Pastural, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematol Oncol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1756-8722-2-28"}], "href": "https://doi.org/10.1186/1756-8722-2-28"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19602237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19602237"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Noman Mohammod Abu Shadat, Naoki Koide, Imtiaz I-E Khuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Retinoblastoma protein-interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Invest (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/07357907.2010.494323"}], "href": "https://doi.org/10.3109/07357907.2010.494323"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20594067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20594067"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Naoki Mori, Kentaro Yoshinaga, Kaori Tomita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2010.08.002"}], "href": "https://doi.org/10.1016/j.leukres.2010.08.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20828818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20828818"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Qingnan Liu, Xiaotian Qu, Xiaolei Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Repression of Akt3 gene transcription by the tumor suppressor RIZ1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-19943-5"}], "href": "https://doi.org/10.1038/s41598-018-19943-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29367689"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29367689"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Marzia Di Donato, Erika Di Zazzo, Annamaria Salvati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-023-04621-6"}], "href": "https://doi.org/10.1186/s12967-023-04621-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37853459"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37853459"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Osam Sasaki, Kuniaki Meguro, Yasuo Tohmiya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nucleotide alteration of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tohoku J Exp Med (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1620/tjem.196.193"}], "href": "https://doi.org/10.1620/tjem.196.193"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12002276"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12002276"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Micaela Poetsch, Thomas Dittberner, Christian Woenckhaus "}, {"type": "b", "children": [{"type": "t", "text": "Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1205457"}], "href": "https://doi.org/10.1038/sj.onc.1205457"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12082534"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12082534"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yutaka Tokumaru, Shuji Nomoto, Carmen Jerónimo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biallelic inactivation of the RIZ1 gene in human gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1206403"}], "href": "https://doi.org/10.1038/sj.onc.1206403"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14534544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14534544"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Mariangela Rossi, Ciro Abbondanza, Andrea D'Arcangelo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2004.05.014"}], "href": "https://doi.org/10.1016/j.canlet.2004.05.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15488642"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15488642"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Janos Geli, Brita Nord, Tony Frisk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15809732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15809732"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Arancha Cebrian, Paul D Pharoah, Shahana Ahmed, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variants in epigenetic genes and breast cancer risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgi375"}], "href": "https://doi.org/10.1093/carcin/bgi375"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16501248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16501248"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Geeta Lal, Lakshmi Padmanabha, Brian J Smith, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncr.22325"}], "href": "https://doi.org/10.1002/cncr.22325"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17103461"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17103461"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "H Y Cheng, Y Gao, Ge Lou "}, {"type": "b", "children": [{"type": "t", "text": "DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Med Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/2047-783x-15-1-20"}], "href": "https://doi.org/10.1186/2047-783x-15-1-20"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20159667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20159667"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "T Harsløf, L B Husted, M Carstens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotypes and haplotypes of the estrogen receptor genes, but not the retinoblastoma-interacting zinc finger protein 1 gene, are associated with osteoporosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Calcif Tissue Int (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00223-010-9375-y"}], "href": "https://doi.org/10.1007/s00223-010-9375-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20508921"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20508921"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Cuijuan Zhang, Hiuming Li, Yan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jhep.2010.05.012"}], "href": "https://doi.org/10.1016/j.jhep.2010.05.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20675009"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20675009"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Janos Geli, Nimrod Kiss, Per Kogner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of RIZ in biologically unfavourable neuroblastomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo_00000784"}], "href": "https://doi.org/10.3892/ijo_00000784"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20878080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20878080"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Hanae Shimura, Naoki Mori, Yan-Hua Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant methylation and decreased expression of the RIZ1 gene are frequent in adult acute lymphoblastic leukemia of T-cell phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Lymphoma (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/10428194.2012.663086"}], "href": "https://doi.org/10.3109/10428194.2012.663086"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22300346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22300346"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Shang-Wen Dong, Peng Zhang, Yi-Mei Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.v18.i6.576"}], "href": "https://doi.org/10.3748/wjg.v18.i6.576"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22363126"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22363126"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Shang-Wen Dong, Yuan-Tao Cui, Rong-Rong Zhong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Lab (2012)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22372344"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22372344"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Prasong Khaenam, Akiko Niibori, Seiji Okada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Contribution of RIZ1 to regulation of proliferation and migration of a liver fluke-related cholangiocarcinoma cell."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Asian Pac J Cancer Prev (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7314/apjcp.2012.13.8.4007"}], "href": "https://doi.org/10.7314/apjcp.2012.13.8.4007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23098508"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23098508"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Shang-Wen Dong, Dong Li, Cong Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alteration in gene expression profile and oncogenicity of esophageal squamous cell carcinoma by RIZ1 upregulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.v19.i37.6170"}], "href": "https://doi.org/10.3748/wjg.v19.i37.6170"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24115813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24115813"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Shuang-Xiang Tan, Rui-Cheng Hu, Jing-Jing Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2014)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24966940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24966940"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Shang-Wen Dong, Hao Zhang, Bao-Li Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of the downregulation of SMYD3 expression by RNAi on RIZ1 expression and proliferation of esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2014.3307"}], "href": "https://doi.org/10.3892/or.2014.3307"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24993551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24993551"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Hua Gao, Fei Wang, Xiaolei Lan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-015-1267-0"}], "href": "https://doi.org/10.1186/s12885-015-1267-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25884948"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25884948"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Peng Ge, Xi Yu, Zi-Cheng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Asian Pac J Cancer Prev (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7314/apjcp.2015.16.9.4071"}], "href": "https://doi.org/10.7314/apjcp.2015.16.9.4071"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25987089"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25987089"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Chenran Zhang, Qiubei Zhu, Hua He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RIZ1: a potential tumor suppressor in glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-015-2023-1"}], "href": "https://doi.org/10.1186/s12885-015-2023-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26690953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26690953"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Elin Grundberg, Kristina Akesson, Andreas Kindmark, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The impact of estradiol on bone mineral density is modulated by the specific estrogen receptor-alpha cofactor retinoblastoma-interacting zinc finger protein-1 insertion/deletion polymorphism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2006-1572"}], "href": "https://doi.org/10.1210/jc.2006-1572"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17356055"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17356055"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Li-Bo Chen, Jun-Yao Xu, Zhen Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.v13.i43.5718"}], "href": "https://doi.org/10.3748/wjg.v13.i43.5718"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17963297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17963297"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Lisette Stolk, Joyce B J van Meurs, Pascal P Arp, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The RIZ Pro704 insertion-deletion polymorphism, bone mineral density and fracture risk: the Rotterdam study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bone (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bone.2007.10.008"}], "href": "https://doi.org/10.1016/j.bone.2007.10.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18037365"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18037365"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Ciro Abbondanza, Filomena de Nigris, Caterina De Rosa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3727/096504008784046081"}], "href": "https://doi.org/10.3727/096504008784046081"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18488713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18488713"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Valentina Rossi, Stefania Staibano, Ciro Abbondanza, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.21920"}], "href": "https://doi.org/10.1002/jcp.21920"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19746436"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19746436"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Wanpeng Sun, Ling Qiao, Qiang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Anticancer activity of the PR domain of tumor suppressor RIZ1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Med Sci (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijms.8.161"}], "href": "https://doi.org/10.7150/ijms.8.161"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21369371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21369371"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Rashid Mir, Imtiyaz Ah Najar, Sameer Guru, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A deletion polymorphism in the RIZ gene is associated with increased progression of imatinib treated chronic myeloid leukemia patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Lymphoma (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/10428194.2016.1251589"}], "href": "https://doi.org/10.1080/10428194.2016.1251589"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27830966"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27830966"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Yake Xue, Ruokun Chen, Wei Du, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RIZ1 and histone methylation status in pituitary adenomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317711794"}], "href": "https://doi.org/10.1177/1010428317711794"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28718376"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28718376"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Dong Wei, Chen Yiyuan, Liu Qian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The absence of PRDM2 involved the tumorigenesis of somatotroph adenomas through regulating c-Myc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2020.144456"}], "href": "https://doi.org/10.1016/j.gene.2020.144456"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32044406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32044406"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Erika Di Zazzo, Monica Rienzo, Amelia Casamassimi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-023-04066-x"}], "href": "https://doi.org/10.1186/s12967-023-04066-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36964555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36964555"}]}]}]}
Synonyms HUMHOXY1, KMT8, KMT8A, RIZ, RIZ1, MTB-ZF, RIZ2
Proteins PRDM2_HUMAN
NCBI Gene ID 7799
API
Download Associations
Predicted Functions View PRDM2's ARCHS4 Predicted Functions.
Co-expressed Genes View PRDM2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View PRDM2's ARCHS4 Predicted Functions.

Functional Associations

PRDM2 has 6,444 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 127 datasets.

Click the + buttons to view associations for PRDM2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by PRDM2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of PRDM2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of PRDM2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of PRDM2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of PRDM2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of PRDM2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of PRDM2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of PRDM2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of PRDM2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of PRDM2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of PRDM2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of PRDM2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of PRDM2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with PRDM2 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with PRDM2 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRDM2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of PRDM2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of PRDM2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of PRDM2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing PRDM2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing PRDM2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing PRDM2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with PRDM2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with PRDM2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of PRDM2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with PRDM2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with PRDM2 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with PRDM2 gene/protein from the curated CTD Gene-Disease Associations dataset.
dbGAP Gene-Trait Associations traits associated with PRDM2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of PRDM2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by PRDM2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with PRDM2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with PRDM2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with PRDM2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with PRDM2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with PRDM2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at PRDM2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRDM2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of PRDM2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing PRDM2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with PRDM2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with PRDM2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of PRDM2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with PRDM2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing PRDM2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of PRDM2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of PRDM2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of PRDM2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of PRDM2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of PRDM2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of PRDM2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving PRDM2 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving PRDM2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving PRDM2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing PRDM2 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing PRDM2 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing PRDM2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by PRDM2 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by PRDM2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by PRDM2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of PRDM2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of PRDM2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of PRDM2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of PRDM2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with PRDM2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with PRDM2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with PRDM2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of PRDM2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for PRDM2 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of PRDM2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of PRDM2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of PRDM2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of PRDM2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for PRDM2 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with PRDM2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by PRDM2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for PRDM2 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of PRDM2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of PRDM2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of PRDM2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate PRDM2 protein from the curated KEA Substrates of Kinases dataset.
KEGG Pathways 2026 pathways involving PRDM2 protein from the KEGG Pathways 2026 dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate PRDM2 protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of PRDM2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of PRDM2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with PRDM2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of PRDM2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of PRDM2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of PRDM2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of PRDM2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing PRDM2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain PRDM2 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by PRDM2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting PRDM2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of PRDM2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of PRDM2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by PRDM2 gene mutations from the MPO Gene-Phenotype Associations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of PRDM2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing PRDM2 protein recovered by IP-MS from the NURSA Protein Complexes dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for PRDM2 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of PRDM2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of PRDM2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving PRDM2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving PRDM2 protein from the Wikipathways PFOCR 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of PRDM2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of PRDM2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of PRDM2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of PRDM2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of PRDM2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at PRDM2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of PRDM2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of PRDM2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of PRDM2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands ligand (protein) perturbations changing phosphorylation of PRDM2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of PRDM2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of PRDM2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of PRDM2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of PRDM2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of PRDM2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of PRDM2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of PRDM2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of PRDM2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of PRDM2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with PRDM2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with PRDM2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving PRDM2 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving PRDM2 protein from the WikiPathways Pathways 2024 dataset.